Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $69.74 million. The enterprise value is $243.41 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 53.24 million shares outstanding. The number of shares has increased by 21.15% in one year.
| Current Share Class | 53.24M |
| Shares Outstanding | 53.24M |
| Shares Change (YoY) | +21.15% |
| Shares Change (QoQ) | +1.71% |
| Owned by Insiders (%) | 2.57% |
| Owned by Institutions (%) | 37.74% |
| Float | 46.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | 0.32 |
| PB Ratio | 1.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 3.75.
| Current Ratio | 1.16 |
| Quick Ratio | 1.11 |
| Debt / Equity | 3.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.02 |
Financial Efficiency
Return on equity (ROE) is -136.44% and return on invested capital (ROIC) is -10.02%.
| Return on Equity (ROE) | -136.44% |
| Return on Assets (ROA) | -7.95% |
| Return on Invested Capital (ROIC) | -10.02% |
| Return on Capital Employed (ROCE) | -24.56% |
| Revenue Per Employee | $586,346 |
| Profits Per Employee | -$403,826 |
| Employee Count | 454 |
| Asset Turnover | 0.59 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.78% in the last 52 weeks. The beta is 1.27, so Cardlytics's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | -62.78% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 2.61 |
| Relative Strength Index (RSI) | 38.08 |
| Average Volume (20 Days) | 2,378,940 |
Short Selling Information
The latest short interest is 6.44 million, so 12.09% of the outstanding shares have been sold short.
| Short Interest | 6.44M |
| Short Previous Month | 6.42M |
| Short % of Shares Out | 12.09% |
| Short % of Float | 13.92% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, Cardlytics had revenue of $266.20 million and -$183.34 million in losses. Loss per share was -$3.56.
| Revenue | 266.20M |
| Gross Profit | 115.71M |
| Operating Income | -56.98M |
| Pretax Income | -153.33M |
| Net Income | -183.34M |
| EBITDA | -31.51M |
| EBIT | -56.98M |
| Loss Per Share | -$3.56 |
Full Income StatementBalance Sheet
The company has $46.75 million in cash and $220.41 million in debt, giving a net cash position of -$173.67 million or -$3.26 per share.
| Cash & Cash Equivalents | 46.75M |
| Total Debt | 220.41M |
| Net Cash | -173.67M |
| Net Cash Per Share | -$3.26 |
| Equity (Book Value) | 58.71M |
| Book Value Per Share | 1.11 |
| Working Capital | 21.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.12 million and capital expenditures -$1.07 million, giving a free cash flow of -$2.19 million.
| Operating Cash Flow | -1.12M |
| Capital Expenditures | -1.07M |
| Free Cash Flow | -2.19M |
| FCF Per Share | -$0.04 |
Full Cash Flow StatementMargins
Gross margin is 43.47%, with operating and profit margins of -21.41% and -68.87%.
| Gross Margin | 43.47% |
| Operating Margin | -21.41% |
| Pretax Margin | -68.87% |
| Profit Margin | -68.87% |
| EBITDA Margin | -11.84% |
| EBIT Margin | -21.41% |
| FCF Margin | n/a |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.15% |
| Shareholder Yield | -21.15% |
| Earnings Yield | -262.89% |
| FCF Yield | -3.14% |
Analyst Forecast
The average price target for Cardlytics is $3.25, which is 148.09% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.25 |
| Price Target Difference | 148.09% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -4.49 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.49 |
| Piotroski F-Score | 3 |